Inhibition of fibulin-3 enhances macrophage activation, indicating a shift in immunosuppressive signaling in glioblastoma.
Supplementary Figure S9. Anti-fibulin-3 triggers myeloid cell attack against syngeneic GBM cells.
No takes yet. Share an insight, caveat, or question.
Kundu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: